Search PLUS
EPLUS INC
Nasdaq · CIK 1022408
Last close93.4
Daily change+0.51 (0.55%)
10 Years gain+298.74%
Dividends TTM1.04 (+316.00%)
Dividend yield1.12%
Fundamental Analysis
PLUS · STANDARD
SIC 5045 · Wholesale-Computers & Peripheral Equipment & Software · Fiscal year end 0331
Fundamental
64.9Momentum
56.8Acceleration
70.9Confidence
91.0Annual Revenue17
Quarterly Revenue68
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth14.8 / 25
Quality11.6 / 25
Capital Efficiency11.5 / 20
Balance Sheet15.0 / 15
Shareholder Economics9.3 / 10
Forward Indicators2.8 / 5
Signals
Operating leverageOperating margin improved by 1.3585 percentage points.
ROIC expansionROIC improved by 8.3962 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 2.0962%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Warnings
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Key Metrics
Revenue Growth TTM23.84%OK
Revenue CAGR 3Y5.71%OK
Gross Margin24.88%OK
Operating Margin6.92%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC18.89%OK
Incremental Operating Margin 3Y4.08%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-2.1%OK
SBC / Revenue0.49%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Mar 31, 2026 | $2.44B | $616.08M | $166.15M | -$116.23M | -$120.66M | 25.22% | 6.8% | -4.94% | 18.6% | 26.37M |
| 2026 FY Mar 31, 2025 | $2.00B | $512.12M | $99.69M | $302.15M | $296.87M | 25.6% | 4.98% | 14.84% | 11.36% | 26.67M |
| 2026 FY Mar 31, 2024 | $2.18B | $511.74M | $133.81M | $248.45M | $240.79M | 23.49% | 6.14% | 11.05% | 14.62% | 26.72M |
| 2025 FY Mar 31, 2023 | $2.07B | $517.52M | $166.16M | -$15.43M | n/a | 25.03% | 8.04% | n/a | 20.66% | 26.65M |
| 2024 FY Mar 31, 2022 | $1.82B | $460.98M | $147.32M | -$20.57M | n/a | 25.31% | 8.09% | n/a | 22.58% | 26.87M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $2.52B | sum latest 4 fiscal quarters Revenue | OK | 0001140361-26-031274, 0001140361-25-040814 |
| Revenue Growth TTM | 23.84% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001140361-26-031274, 0001140361-25-040814 |
| Revenue CAGR 3Y | 5.71% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001140361-26-023171 |
| Revenue CAGR 5Y | 9.27% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001140361-26-023171 |
| Gross Profit CAGR 3Y | 5.98% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001140361-26-023171 |
| Operating Income Growth | 54.09% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001140361-26-031274, 0001140361-25-040814 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 24.88% | Gross Profit / Revenue | OK | 0001140361-26-031274, 0001140361-25-040814 |
| Operating Margin | 6.92% | Operating Income / Revenue | OK | 0001140361-26-031274, 0001140361-25-040814 |
| ROIC | 18.89% | NOPAT / Average Invested Capital | OK | 0001140361-26-031274, 0001140361-25-040814 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001140361-26-031274 |
| Current Ratio | 2.13x | Current Assets / Current Liabilities | OK | derived |
| SBC / Revenue | 0.49% | SBC / Revenue | OK | 0001140361-26-031274, 0001140361-25-040814 |
| Revenue per Diluted Share | $96.52 | Revenue / Diluted Shares | OK | 0001140361-26-031274, 0001140361-25-040814 |